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Lymphatic vessels arise chiefly from preexisting em-
bryonic veins. Genetic regulators of lymphatic fate
are known, but how dynamic cellular changes
contribute during the acquisition of lymphatic identity
isnotunderstood.Wereport thevisualizationofzebra-
fish lymphatic precursor cell dynamics during fate re-
striction. In the cardinal vein, cellular commitment is
linked with the division of bipotential Prox1-positive
precursor cells, which occurs immediately prior to
sprouting angiogenesis. Following precursor division,
identities are established asymmetrically in daughter
cells; one daughter cell becomes lymphatic and pro-
gressively upregulates Prox1, and the other downre-
gulates Prox1 and remains in the vein. Vegfc drives
cell division and Prox1 expression in lymphatic
daughter cells, coupling signaling dynamics with
daughter cell fate restriction and precursor division.INTRODUCTION
To form functioning tissues, individual precursor cells acquire
distinct identities and differentiate under the influence of cell-
cell signaling, growth factor signaling, and mechanical forces.
In the vasculature, lymphatic endothelial cells (LECs) arise pri-
marily from the preexisting venous endothelial cells (VECs) of
the early embryo by spouting from the cardinal vein and subse-
quently migrating to colonize embryonic tissues (Sabin, 1902;
Srinivasan et al., 2007). Overall, the developmental origins of
LECs and the factors promoting lymphangiogenesis are largely
conserved between vertebrates (reviewed in Koltowska et al.,
2013). However, recent findings have suggested diversity in
the origins of LECs in some vascular beds (Klotz et al., 2015; Ma-
hadevan et al., 2014; Martinez-Corral et al., 2015; Stanczuk
et al., 2015).1828 Cell Reports 13, 1828–1841, December 1, 2015 ª2015 The AutIn mice, Prospero-related homeobox domain 1 (PROX1) is ex-
pressed in the dorsal wall of the cardinal vein (CV) from embry-
onic day 9.5 (E9.5) and is thought to mark specified LECs (Wigle
et al., 2002; Wigle and Oliver, 1999). PROX1 is essential for
lymphatic vessel development in mice and has the capability
to direct LEC fate when overexpressed in endothelial cells
(ECs) (Hong et al., 2002; Kim et al., 2010;Wigle et al., 2002;Wigle
and Oliver, 1999; Yang et al., 2012). Once LECs induce PROX1
expression, these cells vacate the CV, sprouting in response to
signaling induced by VEGFC, through its receptor VEGFR3 (Ha¨-
gerling et al., 2013; Karkkainen et al., 2004).
Zebrafish secondary angiogenic sprouts emerge from the
posterior CV (PCV) from 36 hr postfertilization (hpf) and generate
either venous intersegmental vessels (vISVs) or alternating
lymphatic precursors, which have sprouted to the horizontal my-
oseptum (HM) by 48 hpf (Bussmann et al., 2010; Hogan et al.,
2009a; Isogai et al., 2009; Yaniv et al., 2006). This process de-
pends on Vegfc, Ccbe1, and Vegfr3 (Flt4) signaling as in mice
(Hogan et al., 2009a, 2009b; Villefranc et al., 2013). However,
the developmental stage when lymphatic precursors become
fate restricted in zebrafish has been contentious (Geudens
et al., 2010; Koltowska et al., 2013; van Impel et al., 2014).
Recent observations have suggested that LECs may arise well
in advance of secondary sprouting from the PCV, from a pool
of ventral PCV angioblasts from 24 hpf (Nicenboim et al.,
2015). These ventral angioblasts are multipotent, generating
arterial ECs (AECs), VECs (in the sub-intestinal vasculature),
and secondary sprouts (Nicenboim et al., 2015). However, the
dynamics of LEC fate commitment remain unclear, and the mo-
lecular control of this process remains to be fully understood.
Here, we took advantage of an optimized transgenic line that
reports prox1a expression and staged analysis of Prox1 protein
distribution. Live imaging of precursors in the PCV revealed a cell
division preceding secondary sprouting that generates two
daughter cells with distinct identities. One daughter remains a
VEC in the PCV and the other becomes a LEC and migrates
out of the CV, progressively upregulating prox1a. These bipo-
tential precursors arise between 30 and 34 hpf, when Prox1hors
(legend on next page)
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expression is initiated. Mechanistically, Vegfc is necessary for
precursor cell division and prox1a/Prox1 expression, identifying
an earlier role for Vegfc than previously reported. The post-divi-
sion restriction of LEC fate to a single daughter couples cell
behavior and signaling dynamics with the restriction of identity
in this vascular lineage.
RESULTS
Lymphatic Precursors Express Prox1 Prior to and
Concomitant with Sprouting from the PCV
Zebrafish have two Prox1 paralogs, with prox1a faithfully
marking lymphatics but prox1b absent from lymphatics (Dun-
worth et al., 2014; Tao et al., 2011). It is currently unclear when
prox1a expression and LEC identity are acquired (Dunworth
et al., 2014; Nicenboim et al., 2015; van Impel et al., 2014). To
determine the point at which LECs differ from other secondary
sprouts, we examined the expression of Tg(prox1a:KalTA4-
4xUAS:uncTagRFP) (henceforth prox1a:TagRFP). We detected
expression in cells emerging from the PCV at 36 hpf and occa-
sional weak expression in the PCV at 32 hpf (Figure 1A). As
this line relies on KalTA4 and 4xUAS, we enhanced expression
levels by introducing a Tg(10xUAS:Venus) transgene (Figures
1A and 1B). This improved tool (henceforth prox1a:Venus) re-
vealed robust Venus-expressing cells in the wall of the PCV
from 32 hpf (Figure 1A). We also generated a transgenic line
that did not express TagRFP: Tg(prox1a:KalTA4);Tg(10xUAS:
Venus) to examine prox1a-positive cells present in the dorsal
aorta (DA), ISVs, PCV, and secondary sprouts (vISVs and
parachordal lymphangioblasts [PLs]) by colocalization with
Tg(kdrl:mCherry) in the blood vasculature (Figure 1C). At 48
hpf, 78% of prox1a expressing cells were PLs (Figures 1C and
1E) 16% were vISVs and 6% were ECs present in the PCV
(Figure 1E).
To determine the degree to which this transgene expression
reflected endogenous Prox1 distribution, we used immunofluo-Figure 1. Prox1 Is Expressed and Required in Lymphatic Precursors d
(A) Single confocal projection of a TagRFP-low (left), Venus-high (middle) cell loc
posterior cardinal vein; pre-LEC, LEC precursor (arrowheads). Scale bars, 50 mm
(B) Developmental time series of prox1a:Venus expression. PCV, posterior cardin
TD, thoracic duct. Scale bars, 50 mm.
(C) Tg(prox1a:KALTA4);Tg(10xUAS:Venus) expression (green) in a sprouting LEC (
at 2 dpf. vISV, venous intersegmental vessel. Scale bars, 30 mm. Blood vasculat
(D) Endogenous Prox1-positive (gray) PLs (arrowheads) in the trunk co-labeled b
(E) Percentage of total prox1a:Venus- and Prox1-expressing (endogenous) cells lo
or parachordal lymphangioblasts (PL) at 2 dpf.
(F) Endogenous Prox1-positive (gray) secondary sprouts (arrowheads) and nega
green. Scale bar, 30 mm.
(G) Prox1-positive (gray) nuclei located in the dorsal wall of the PCV at 32 hpf (Tg
(H) Mean percentage of Prox1-positive and Prox1-negative secondary sprouts
34.55% ± 3.236, n = 15 embryos scored across n = 6 body segments).
(I) Maximum intensity projections of Tg(fli1a:nEGFP) (endothelial nuclei, green) and
(top), Zprox1a (middle), and MZprox1a (bottom) mutant embryos at 4 dpf. ISLV,
lymphatic vessel. Asterisks indicate missing lymphatic structures. Scale bar, 50
(J) Box and whiskers (min to max) plot of the number of trunk lymphatic nuclei at 4
(n = 6mutants, n = 10 siblings, 33% reduction), pair2 (n = 7mutants, n = 6 siblings,
mutants, n = 7 siblings, 32% reduction).
(K) Total number of trunk lymphatic nuclei at 4 dpf in sibling (n = 34), Zprox1amuta
body segments) (t test sibling versus Zprox1a ****p < 0.0001 and Zprox1a versus
1830 Cell Reports 13, 1828–1841, December 1, 2015 ª2015 The Autrescence (IF). At 48 hpf, Prox1 protein was found only in PLs at
the HM and not in any other trunk vasculature (Figures 1D and
1E), and hence the transgene overrepresents the breadth of
Prox1 expression. Comparison of transgene and Prox1-pro-
tein-expressing PLs revealed that the transgene is also more
mosaic than endogenous Prox1, which is highly restricted and
present in all PLs by 2 dpf (Figure 1D; data not shown). These
differences are probably due to a combination of the KalTA4-
UAS nature of the transgene and the perdurance of Venus re-
porter protein.
To determine the earliest point when Prox1 protein distribution
is restricted, we analyzed 36 hpf embryos when secondary
sprouts are emerging from the PCV. We used IF and found that
the average percentage of Prox1-positive secondary sprouts
per embryo was 65%. The remaining 35% were negative (from
n = 15 embryos scored with high resolution across n = 6 seg-
ments), indicating that two discrete cell types emerge from
the PCV (Figures 1F and 1H). Finally, we found that vascular
Prox1 was detectable by 32 hpf (Figure 1G). Hence, ECs express
Prox1 preceding secondary angiogenesis, but secondary
sprouts are heterogeneous as they emerge from the PCV.
The Critical Role of Prox1 in Lymphangiogenesis Is
Conserved in Zebrafish
Prox1 expression serves as a suitable marker of LEC identity in
zebrafish, as it does in the mouse. However, the functional
contribution of Prox1 homologs in zebrafish has also been
contentious (Tao et al., 2011; van Impel et al., 2014). We
analyzed the phenotype of prox1ai278 mutants by precise quan-
tification of total trunk LEC numbers using the overlay of a
vascular nuclear EGFP marker and the venous and lymphatic
transgenic marker Tg(5.2lyve1:DsRed). As has been previously
reported, we observed amild loss of LECs in prox1ai278mutants,
with an average reduction of 33% across multiple breeding pairs
and up to 41% of LECs at 4 dpf in some pairs (Figures 1I and 1J).
This variable phenotype in zygotic mutants is significant, yeturing Secondary Sprouting
ated in the wall of the PCV (bright field, right) at 32 hpf. DA, dorsal aorta; PCV,
.
al vein; LEC, lymphatic endothelial cell; ISLV, intersegmental lymphatic vessel;
above, arrowhead) and a parachordal lymphangioblast (PL, below, arrowhead)
ure in red (Tg(kdrl:mCherry)).
y Tg(fli1a:nEGFP) (a-GFP, green. Scale bar, 30 mm.
cated in the posterior cardinal vein (PCV), venous intersegmental vessels (vISV),
tive secondary sprouts (asterisk) at 36 hpf (Tg(fli1a:nEGFP) labeled by a-GFP,
(fli1a:nEGFP) labeled by a-GFP, green. Scale bar, 30 mm.
per embryo at 36 hpf (Prox1 positive 65.45% ± 3.236 SEM, Prox1 negative
Tg(5.2lyve1b:DsRed) (PCV and lymphatic vessels, gray) in the trunk of sibling
intersegmental lymphatic vessel; TD, thoracic duct; DLLV, dorsal longitudinal
mm.
dpf in sibling and Zprox1amutants (scored across n = 7 body segments): pair1
41% reduction), pair3 (n = 6mutants, n = 4 siblings, 26% reduction), pair4 (n = 9
nts (n = 32) and MZprox1amutants (n = 24) (mean ± SEM, scored across n = 7
MZprox1a ****p < 0.0001) (Zprox1b mutants [red], prox1b siblings [black]).
hors
much milder than observed in mice (Wigle et al., 2002; Wigle
and Oliver, 1999). We hypothesized that the reduced pene-
trance may be due to prox1a maternal deposition, as has been
reported (Pistocchi et al., 2008a, 2008b). Hence, we generated
maternal zygotic (MZ) prox1a mutants by germline transfer (Cir-
una et al., 2002). Specifically, we generated germline
MZprox1ai278/;prox1bsa0035+/ females and crossed them to
prox1ai278+/;prox1bsa0035+/ males. We observed a vast reduc-
tion in the total number of embryonic LECs in MZprox1ai278 mu-
tants compared to zygotic (Z) prox1ai278 mutants and siblings
(Figures 1I and 1K). We saw little evidence for a contribution of
a zygotic prox1b mutant allele to MZprox1a phenotypic severity
(red data points in Figure 1K are MZprox1a/Zprox1b mutants).
Overall, this mutant analysis reveals a robust contribution of
Prox1 homologs in zebrafish lymphangiogenesis, confirming
the essential nature of the restricted Prox1 expression described
above.
The PCV Becomes Structurally Polarized before Prox1
Induction and Secondary Angiogenesis
To better understand the timing of Prox1 induction, we next
performed a carefully staged analysis of PCV morphogenesis
and Prox1/prox1a expression initiation. We examined the dis-
tribution of endothelial nuclei in the PCV in double-transgenic
Tg(fli1a:nEGFP);Tg(kdrl:mCherry) double-transgenic embryos at
26, 30, and 36 hpf (Figures 2A and 2B). Nuclei were evenly
distributed around the 26 hpf PCV, but at 30 hpf, and even
more prominently at 36 hpf, EC nuclei were increased in number
in the dorsal half of the PCV (Figure 2B). Hence, venous morpho-
genesis involves the establishment of a dorsoventrally polarized
tube preceding the dorsal sprouting that occurs during second-
ary angiogenesis.
We examined Prox1 protein expression at 24, 30, 32, and 36
hpf. Nuclear Prox1 protein was rarely observed at 24 hpf, found
in only 3 ventral PCV cells from n = 15 embryos scored across 7
somites (Figures 2C and 2D). At 30 hpf, only 2 dorsal PCV cells
were observed from n = 10 embryos, but at 32 hpf, high numbers
of Prox1-positive cells were observed in the PCV and highly en-
riched in the dorsal PCV. Further increased numbers of dorsal
Prox1-positive cells were observed by 36 hpf (Figures 2C and
2D). We also quantified Prox1 fluorescence intensity at these
time points relative to expression in nearby trunk neurons (Fig-
ure S1). We found that Prox1 expression progressively increases
in developing LEC precursors (Figures 2E and 2F). These data
demonstrate a predominantly dorsal induction of Prox1 protein
expression in the PCV, following polarization of the vein, be-
tween 32 and 36 hpf (Figure 2G).
Interestingly, when we examined the prox1a:Venus;Tg(kdrl:
mCherry) line, we found that transgene expression was broader
throughout the PCV than endogenous protein distribution from
24 to 30 hpf (Figure S1). By 36 hpf, the transgene was more
highly enriched in dorsally sprouting cells (Figure S1), again
suggesting that the transgene overrepresents distribution of
Prox1 protein at early, but not later, stages. Importantly, both
endogenous Prox1-expressing cells in the PCV and trans-
gene-expressing cells were endothelial by co-expression of
Tg(fli1a:nEGFP), Tg(5.2lyve1:DsRed) and Tg(kdrl:mCherry)
(Figures 1C, 2A, and S1).Cell ReProx1a-Positive Precursors Divide in the PCV and Give
Rise to Both Lymphatic and Venous Daughter Cells
The dynamic process of commitment to LEC identity by VECs
has not previously been observed in real time during develop-
ment. We performed live imaging of prox1a:Venus beginning at
30 hpf. Analysis of time-lapse movies revealed a distinctive divi-
sion of prox1a-positive cells in the PCV prior to sprouting.
Following this, daughter cells behaved asymmetrically, as one
daughter remained in the vein while the other migrated dorsally
to the HM (Movie S1). Quantification of cell behavior during PL
formation from n = 19 independent movies revealed that this
daughter cell behavior followed a cell division in 84% of cases
in prox1a-expressing cells (Figure 3B). In the remaining 16% of
cases, a cell division preceded both daughter cells migrating
to the HM, and we did not observe PL formation without a pre-
ceding cell division in PCV (Figure 3B).
To determine if these distinct daughter cell behaviors reflect
different molecular identities following cell division, we quantified
prox1a reporter expression. We injected DNA encoding nuclear
H2AmCherry and membranous EGFP driven from a 10xUAS
element into prox1a:TagRFP (uncTagRFP is nuclear excluded,
KalTA4 is present) and labeled individual prox1a-positive nuclei
over time (Figure 3A; Movie S2). We quantified average nuclear
pixel intensity of H2AmCherry in ECs throughout the time lapse
and found that after cell division, the nucleus of the dorsal
migrating daughter cell displayed increasing prox1a compared
with the ventral daughter (Figures 3A0 and 3C; Movie S3).
Demonstrating reproducibility, the ratio of average prox1a pixel
intensity per nucleus for ‘‘dorsally migrating daughter cell
(LEC)’’ over ’’ventral daughter cell (VEC)’’ continuously increased
after division across multiple movies (Figure 3D). There were no
consistent changes in nuclei Z-position or ellipticity during these
movies (Figures 3E, 3F, and S2). The loss of expression in the
venous daughter was consistent with a lack of prox1a/Prox1 in
the PCV by 48 hpf (see Figures 1C–1E). In addition, we analyzed
endogenous Prox1 levels in isolated, closely neighboring prox1a:
Venus-positive cells (doublets) located in the PCV at 36 hpf. We
found that in 76% of doublets, Prox1 protein was restricted to
the putatively sprouting, dorsal prox1a:Venus-positive LEC and
not present in the prox1a:Venus-positive VECs in the PCV wall,
suggesting rapid restriction of Prox1 expression to one daughter
cell post-division (Figures 3G and 3H).
Together, these data show that bipotential prox1a:Venus/
Prox1-positive cells divide in the PCV from 30 hpf, giving rise
to daughter cells with asymmetric behaviors and identities.
One daughter is a VEC and remains in the PCV and the other is
a LEC and migrates dorsally, elevating prox1a transcription
and Prox1 protein levels.
Live Imaging of PCV Nuclei Confirms Bipotential
Precursor and Daughter Cell Dynamics
We next tracked individual nuclei using the Tg(fli1a:GALFF);
Tg(4xUAS:RFP);Tg(fli1a:nEGFP) line (Figure 4A and 4A0; Movie
S4). We examined n = 11 movies and were able to accurately
track both LECs and VECs after division in just n = 3 due to the
high concentration of dorsal nuclei in the PCV. These movies
confirmed behaviors seen using prox1a:Venus, with division pre-
ceding dorsal migration of one daughter and the other daughterports 13, 1828–1841, December 1, 2015 ª2015 The Authors 1831
Figure 2. The PCV Becomes Structurally Polarized and Initiates Prox1 Expression before Secondary Angiogenesis
(A) Confocal projection of Tg(fli1a:nEGFP);Tg(kdrl:mCherry) labeling endothelial cell (EC) nuclei (green) and membrane (red) showing the PCV (upper) and
rendered signal (lower) at 26, 30, and 36 hpf (scored across 3 body segments). D, dorsal; V, ventral. Scale bar, 30 mm.
(B) Quantification of EC number in the dorsal (black circles) and ventral (gray squares) halves of the PCV scored in lateral projections at 26 hpf (n = 10), 30 hpf
(n = 16), and 36 hpf (n = 10) (scored across 3 body segments) (mean ± SEM).
(C) Endogenous Prox1 (gray, lower) in the trunk vasculature of Tg(fli1a:nEGFP) embryos (a-GFP, green, top) at 24, 30, and 36 hpf (scored across 3 body
segments). Scale bar, 30 mm.
(D) Quantification of the number of Prox1 positive ECs in dorsal and ventral halves of the PCV at 24 hpf (n = 15), 30 hpf (n = 10), 32 hpf (n = 12), and 36 hpf (n = 12)
(scored across 3 body segments) (mean ± SEM).
(E) Heatmap of average intensity projection of Prox1-positive ECs at 32, 36, and 48 hpf. Scale bar, 10 mm.
(F) Quantification of Prox1 protein expression intensity in Tg(fli1a:nEGFP)-positive ECs relative to Prox1 neuronal expression at stages indicated (t test: 32 hpf
versus 36 hpf **p = 0.0013, 36 hpf versus 48 hpf ***p = 0.0007, and 32 hpf versus 48 hpf ****p < 0.0001; mean [SD]).
(G) Schematic representation of PCV polarization and Prox1 induction.remaining in the PCV (Figures 4A and 4A0). To improve this anal-
ysis, we generated cellular mosaic embryos by transplantation
(Figure 4B). We time-lapse imaged mosaic embryos and tracked
EC nuclei through to dorsal migration to the HM, when they can1832 Cell Reports 13, 1828–1841, December 1, 2015 ª2015 The Autbe identified as PLs based on location (Figure 1C; Movies S4 and
S5). This approach revealed asymmetric behavior of daughter
cells post-precursor division in 83% of cases from n = 12 divi-
sions (Figures 4C and 4D; Movies S4 and S5); additionally, thehors
Figure 3. Bipotential prox1a-Positive Precursors in the PCV Give Rise to LECs and VECs
(A) Maximum intensity projections from time lapse of cell division in a prox1a-positive pre-LEC Tg(prox1a:TagRFP) labeled with 10xUAS:H2AmCherry-IRES-
GFPCAAX. Nuclei are red and membranes are green. Scale bars, 15 mm.
(A0) Heatmap of average fluorescent intensity of prox1a:H2AmCherry nuclei depicted in (A) (scale bars, 15 mm).
(B) Percentage daughter cell behaviors observed post-/pre-LEC division (84%, one cell migrating dorsally [2 sprout] and one remaining in the PCV; 16%, both
daughter cells migrate dorsally; and 0%, both daughter cells remaining the PCV [n = 19 cell divisions]).
(C) Average nuclear prox1a:H2AmCherry fluorescent intensity per pixel over time for movies shown in (A) and (A0), prior to division (yellow), LEC (green), and VEC
(blue).
(D) Index of LEC/VEC prox1a:H2AmCherry average nuclear fluorescent intensity per pixel over time taken from n = 4 independent time-lapse movies. Each color
represents an independent division event (movie 1, blue; movie 2, red; movie 3, purple; and movie 4, green).
(E) Difference in z-position of the LEC versus the VEC nucleus over time in corresponding time-lapse movies shown in (D).
(F) Index of LEC/VEC nuclear ellipticity (longest axis/shortest axis) over time of corresponding time-lapse movies in (D).
(G) Endogenous Prox1 (gray) in prox1a:Venus doublets (two cells side by side in isolation in the PCV [green]) at 36 hpf (a Prox1-positive cell [arrowhead]/Prox1-
negative cell [asterisk], n = 18; upper and lower are two different examples. Scale bars, 15 mm.
(H) Percentage of different Prox1 protein distribution patterns in prox1a positive doublets at 36 hpf (n = 21 doublets scored).majority of divisions occurred in the dorsal half of the PCV (Fig-
ure 4E). Importantly, these movies spanned the period when
Prox1 expression turns on in the PCV, through to stages when
Prox1 expression becomes absent from the PCV (from 28 hpf
up to 3 dpf), and we did not observe additional divisions of
VEC daughter cells to contribute additional LECs.
Using this approach, we also observed nuclear dynamics
of cells that contribute to the venous ISVs. 60%of cells migratingCell Reinto a developing vISV were derived from a cell division in which
one daughter cell remained in the PCV (analogous to LEC pre-
cursor behaviors), 10%were derived from a cell division in which
both cells contributed to the forming vISV, and 30% of nuclei
were not immediately derived from a cell division (n = 10 movies;
Figures 4F and S2;Movie S6), a scenario not seen in LEC precur-
sor behaviors. Finally, we quantified nuclear expression intensity
in these Tg(fli1a:nEGFP) ECs (Figures 4G–4I; Movie S7). We sawports 13, 1828–1841, December 1, 2015 ª2015 The Authors 1833
Figure 4. Endothelial Nuclear Dynamics
Reveal Bipotential Precursor Behaviors
(A) Maximum intensity projections from a time
lapse of a dividing LEC precursor (pre-LEC) in the
dorsal wall of the posterior cardinal vein (PCV),
with Tg(fli1a:GALFF);Tg(4xUAS:RFP) in red and
Tg(fli1a:nEGFP) in green (scale bars, 10 mm). DA,
dorsa aorta; VEC, venous endothelial cell.
(A0) Rendered Tg(fli1a:nEGFP) nuclei (gray) corre-
sponding to A (pre-LEC, yellow; VEC, blue; LEC,
green. Scale bars, 10 mm.
(B) Schematic representation of transplantation
approach with genotypes and stages indicated.
(C)Maximum intensity projections from a time lapse
of mosaically Tg(fli1a:nEGFP)-labeled embryo
showing a dividing pre-LEC in the PCV. Scale bars,
12 mm.
(C0) Rendered Tg(fli1a:nEGFP) nuclei (gray) corre-
sponding to (C) (pre-LEC, yellow; VEC, blue; LEC,
green). Scale bars, 10 mm.
(D) Percentage of daughter cell behaviors post pre-
LEC division (83%, one daughter cell migrating
dorsally [2 sprout] and one remaining in the PCV;
17%, both migrate dorsally; and 0%, both remain-
ing in the PCV, from n = 12 cell divisions).
(E) Location of pre-LEC cell divisions within the PCV
from (D). 73% of divisions occur in the dorsal half of
the PCV, 18% at the midline (as shown in Figure 2),
and 9% in the ventral half (n = 11 cell divisions).
(F) Behavior for ECs contributing to vISVs. 60% of
dorsal migration is preceded by cell division with
one daughter cell migrating dorsally (2 sprout) and
one remaining in the PCV, 10% is migration with
both daughter cells migrating dorsally, and 30% is
not preceded by cell division (from n = 10 movies).
(G) Heatmap of average fluorescence intensity of
Tg(fli1a:nEGFP) nuclei depicted in (C) and (C0 ).
Scale bars, 12 mm.
(H) Average nuclear Tg(fli1a:nEGFP) fluorescent
intensity per pixel over time for movies shown in (C)
and (C0).
(I) Index of LEC/VEC Tg(fli1a:nEGFP) average nu-
clear fluorescence intensity per pixel over time
taken from n = 4 time-lapse movies from mosaic
nuclei. Each color represents an independent cell
division.
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Figure 5. Vegfc Signaling Is Necessary for VEC Proliferation and Prox1 Expression
(A) Maximum intensity projection of prox1a:Venus (a-GFP, green) at 36 hpf in control,MO-vegfr3, andMO-vegfc embryos in LEC precursors (arrowheads). PCV,
posterior cardinal vein.
(B) Maximum intensity projection of Tg(fli1a:nEGFP) at 30 hpf in control, MO-vegfr3, and MO-vegfc embryos across two somites in the posterior cardinal vein
(PCV). DA, dorsal aorta.
(C) Quantification of the number of prox1a positive LEC precursors (mean ± SEM) inMO-vegfr3- (n = 27) andMO-vegfc-injected (n = 27) embryos compared to
controls (n = 26). Asterisks indicate significance (ANOVA *p = 0.0456, ****p < 0.0001).
(D) Quantification of VEC number at 30 and 36 hpf in Tg(fli1a:nEGFP) in control (n = 8, n = 12),MO-vegfr3 (n = 10, n = 11) andMO-vegfc (n = 9, n = 10; mean ±SEM).
Asterisks indicate significance (ANOVA *p = 0.0165, ****p = 0.0168).
(E) Fluorescence intensity of prox1a:Venus in confocal projections of lymphatic precursors inMO-vegfr3 andMO-vegfc embryos compared with control cells pre-
and post-division.
(F) Quantification of prox1a:Venus average intensity per pixel in individualMO-vegfr3 (n = 62),MO-vegfc (n = 76), and control precursor cells (n = 75; mean ±SEM).
Asterisks indicate significance (ANOVA **p = 0.0058, ****p < 0.0001).
(G)mRNA expression of kdr, vegfr3, prox1a, and sox18 in FACS ECpopulations from control andMO-vegfc embryos at 30 hpf. Graph represents gene expression
relative to kdrl from three biological repeats (mean ± SEM).
(H) Number of Prox1-protein-positive EC nuclei at 38 hpf inMO-vegfr3 (n = 12),MO-vegfc (n = 12), and control precursor cells (n = 12; mean ±SEM) scored across
six somites. Asterisks indicate significance (ANOVA ****p < 0.0001).no consistent changes in expression between LEC and VEC
daughter cells (Figures 4G–4I), confirming the specificity of the
prox1a findings above.
Vegfc Drives Bipotential Precursor Cell Division and Is
Necessary for Prox1 Expression
Given that restriction of LEC identity occurs with or immediately
following precursor division, we investigated if Vegfc is important
for promoting this division. Vegfc is essential during LEC sprout-
ing from the PCV (Ha¨gerling et al., 2013; Hogan et al., 2009a;
Karkkainen et al., 2004) and regulates VEC proliferation (Helker
et al., 2013; Koltowska et al., 2015). To determine if loss
of Vegfc-Vegfr3 signaling influences LEC specification, we in-
jected prox1a:Venus embryos with the morpholino oligomers
MO-vegfr3 and MO-vegfc, which efficiently phenocopy known
mutants (Kok et al., 2015; Le Guen et al., 2014). We found that
prox1a:Venus-positive cells were still present in the PCV but
significantly reduced in number (Figures 5A and 5C). We quanti-
fied VEC numbers in the PCV and observed at 30 hpf a generalCell Rereduction of VEC numbers in these morphants that was further
pronounced at 36 hpf (Figures 5B and 5D). These data suggest
that Vegfc establishes LEC precursor numbers by generally pro-
moting VEC proliferation.
Although some prox1a transgene transcription was initiated in
Vegfc morphants, we quantified the intensity of prox1a:Venus
expression in LEC precursors in MO-vegfc- and MO-vegfr3-
injected embryos. We observed a dramatic reduction in expres-
sion intensity compared with control prox1a:Venus-positive
precursor cells at 34 hpf (Figures 5E and 5F). Importantly,
prox1a:Venus intensity was reduced in non-dividing morphant
cells compared to both dividing and yet undivided control
precursors (Figure 5E). prox1a:Venus expression in neurons
was unchanged (Figure S3). We also performed qRT-PCR on
fluorescence activated cell-sorted (FACS) ECs from control and
MO-vegfc embryos and found a decrease in prox1a RNA levels
(Figure 5G). Strikingly, when we analyzed Prox1 protein distribu-
tionduring stagesof initiation,we foundanabsenceofECnuclear
Prox1 in MO-vegfc- and MO-vegfr3-injected embryos (Figuresports 13, 1828–1841, December 1, 2015 ª2015 The Authors 1835
5HandS3). Together, these findings indicate that Vegfc signaling
controls prox1a/Prox1 expression in the PCV, exerting control
during the earliest stages in LEC commitment.
Vegfc Is Sufficient to Induce Prox1 Expression in
Embryonic VECs
To understand whether Vegfc signaling is sufficient to modu-
late Prox1 expression, we crossed prox1a:TagRFP to the
Tg(10xUAS:vegfc) strain (henceforth vegfc-induced). prox1a is
expressed broadly in somites, neurons, endodermal organs,
and ECs in the trunk; hence, KalTA4will induce Vegfc expression
broadly, in all tissues where prox1a is expressed. We observed
the previously reported Vegfc-driven venous hyper-sprouting
(Le Guen et al., 2014) and quantified EC nuclei and prox1a-ex-
pressing cells. At 4 dpf, we observed increased VEC numbers
and, remarkably, we observed ectopic expression of prox1a
throughout venous, but not arterial, endothelium (Figures 6A
and S4). Supporting the specificity of this phenotype, we
observed ectopic Prox1 protein (data not shown), and depletion
of Vegfr3 or Ccbe1 rescued the phenotype (Jeltsch et al., 2014;
Le Guen et al., 2014) (Figure S4; Table S1). Using chemical inhib-
itors, we found that the phenotype required intact Mek/Erk
signaling, but not Notch signaling or the presence of Sox18
and Sox7 (Figure S4; Table S1). These data demonstrate that
Vegfc is sufficient to induce prox1a expression in zebrafish
VECs. In this overexpression context, Vegfc signals through
Vegfr3-Mek-Erk to induce VEC proliferation and prox1a.
Vegfc Signaling Regulates Prox1 Expression and
Daughter Cell Behavior
Having observed that Vegfc is sufficient to induce prox1a
expression in embryonic VECs by 4 dpf, we investigated earlier
stages. We first quantified EC nuclei in the PCV of vegfc-induced
embryos at 30 and 36 hpf. Although at 36 hpf the number of PCV
ECs had doubled in vegfc-induced embryos, in 30-hpf embryos,
there was no change in cell number (Figure 6B). Despite this,
ectopic expression of prox1a:Venus and Prox1 protein could
be detected throughout the PCV at both 30 and 36 hpf (Figures
6C–6E). Furthermore, at the level of the PCV, prox1a:Venus dou-
blets were consistently both positive for Prox1 in vegfc-induced
embryos (Figure 6E0), unlike sibling controls (Figures 3G and 3H).
We performed time-lapse imaging of the PCV in prox1a:
Venus;vegfc-induced embryos (Figure 6F; Movies S8 and S9).
Wild-type daughter cells presented typical asymmetric behav-
iors post division (Figure 6F, top, and Figures 3 and 4; Movies
S1, S2, S3, S4, S5, S7, and S8). However, in vegfc-induced em-
bryos we saw a dramatic induction of VEC proliferation and
prox1a expression. In this context, when we examined individ-
ual, isolated precursor cell divisions, this asymmetric behavior
was only observed following 42% of divisions compared with
84% in genetic background-matched controls (Figures 6G and
3B). 35% of divisions gave rise to two dorsally migrating daugh-
ters and in 23% of cases the two daughters remained in the PCV
in vegfc-induced embryos (Figure 6F, bottom, and Figure 6G;
Movies S8 and S9). These data suggest that Vegfc levels deter-
mine prox1a/Prox1 expression levels at stages during the re-
striction of LEC identity and also influence cell behavior at these
stages.1836 Cell Reports 13, 1828–1841, December 1, 2015 ª2015 The AutDISCUSSION
Establishing LEC Identity in Zebrafish
Here, we applied live imaging techniques to reveal an unde-
scribed cellular mechanism during zebrafish lymphangiogene-
sis. Prox1-positive cells form a bipotential precursor pool in the
vein and precursors undergo a Vegfc-regulated cell division to
give rise to both LECs and VECs (see model summarized in Fig-
ure 7). This cell behavior ensures the maintenance of PCV cell
number, allowing for the remarkable exodus of LECs from the
dorsal wall of the PCV to generate a new vascular lineage.
Importantly, this alters our understanding of how commitment
to LEC fate occurs. Specification is defined as a labile phase in
which a cell becomes capable of differentiating autonomously
in a neutral environment and is a key step in cellular commitment
preceding determination (Gilbert, 2000). Prox1-positive cells in
the zebrafish PCV are capable of giving rise to two different
cell types: LECs and VECs. Hence, these cells are competent
but not specified to a single lineage. They are bipotential when
present in the PCV, despite their expression of Prox1. Following
division, specified LECs begin dorsal migration from the PCV,
and these cells upregulate Prox1, further committing as LECs.
Nevertheless, 65% of cells leaving the vein during secondary
angiogenesis express Prox1 (Figure 1H) but only 50% will form
LECs (Bussmann et al., 2010). This suggests plasticity in
commitment during secondary sprouting. It will be interesting
to understand if the progressive commitment to LEC identity in-
volves additional, hard-wired, molecular cues or is stochastic in
nature.
Interestingly, the PCV becomes structurally polarized preced-
ing secondary angiogenesis. These data imply either a patterned
dorsal proliferation of ECs in the PCV or a net movement of cells
from the ventral to dorsal half of the PCV between 26 and 30 hpf.
As proliferation of PCV ECs is equally distributed throughout the
vessel (Nicenboim et al., 2015), the later seems more likely. The
recently described movement of fli1a-, lyve1-, and flt1-positive
cells from the ventral to dorsal PCV in the study by Nicenboim
et al. occurs from 24 hpf (Nicenboim et al., 2015), well before
the divisions reported here. It is likely that these ventral wall an-
gioblast divisions and the movement of daughter cells from the
ventral to dorsal PCV contribute to vessel polarization. We
here report both induction of Prox1 expression and cell divisions
that occur later, following polarization of the PCV and largely
occurring in the dorsal PCV. Hence, we suggest that commit-
ment to LEC fate is a dynamic process that follows the early di-
vision of ventral angioblasts, providing ECs to the dorsal PCV
(from 24 hpf), and involves induction of Prox1 expression in bipo-
tential precursors (from 30 to 32 hpf), precursor cell division (from
32 hpf), and the exodus of LECs from the PCV (from 36 hpf).
Overall, the process represents a mechanism by which cellular
commitment occurs progressively at sequential locations
through the embryo as development proceeds.
Vegfc Signaling as an Upstream Regulator of Prox1
Interestingly, we find that Vegfc signaling acts upstream of Prox1
and is both necessary for normal Prox1 expression and high
Vegfc is sufficient to induce Prox1 in developing VECs. However,
vISVs do not go on to express Prox1 despite responding tohors
Figure 6. Vegfc Is Sufficient to Induce Prox1 Expression and Regulate Daughter Cell Behaviors
(A)Maximum intensity projections of Tg(fli1a:nEGFP) in green and prox1a:TagRFP in red, with Tg(10xUAS:vegfc) (n = 8, vegfc-induced) and sibling (n = 8) embryos
at 4 dpf. ISLV, intersegmental lymphatic vessels; TD, thoracic duct. Scale bar, 40 mm.
(B) Quantification of VEC number at 30 and 36 hpf using Tg(fli1a:nEGFP) in sibling (30 hpf, n = 16; 36 hpf, n = 10 embryos) and vegfc-induced embryos (30 hpf,
n = 11; 36 hpf, n = 10 embryos) (ANOVA ****p < 0.0001; mean [SD]).
(legend continued on next page)
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Figure 7. A Model of LEC Commitment in
Zebrafish
Representation of tissue contributions during ze-
brafish lymphatic development (left panel) and of
cellular events during LEC commitment (right
panel) between 32 and 48 hpf.
From 30 to 32 hpf, cells in the PCV induce Prox1.
These bipotential LEC precursors (pre-LECs) give
rise to LECs and VECs upon Vegfc-dependent cell
division. The VEC will remain in the PCV. The LEC
migrates dorsally in response to Vegfc. Progres-
sive upregulation of Prox1 and fate commitment in
the emergent LEC occur during migration to the
HM. At the HM, LECs have been referred to as
parachordal lymphangioblasts (PLs) or para-
chordal cells (PACs) indicative of their location.
LECs/PLs will give rise to the trunk lymphatic
network.Vegfc. It will be important in future studies to determine how
vISVs remain as blood vascular endothelium and whether this
is a default state in the absence of Prox1 or an actively regulated
process.
Most of our current understanding of LEC fate comes from
studies in mouse where LECs are thought to be specified within
the CV by obtaining PROX1 expression (Srinivasan and Oliver,
2011; Wigle and Oliver, 1999). Once specified, LECs sprout
from the CV to give rise to the lymphatics (Ha¨gerling et al.,
2013; Karkkainen et al., 2004;Wigle andOliver, 1999). The induc-
tion of PROX1 in mouse is regulated by a distinct mechanism
from the maintenance of PROX1 in specified murine LECs (Fran-
c¸ois et al., 2008; Johnson et al., 2008; Srinivasan et al., 2010).
Interestingly, early maintenance of PROX1 requires a regulatory
feed-forward relationship between VEGFR3 and PROX1 in mice
(Srinivasan et al., 2014). This previous finding and our data would
be consistent with a mechanism in which zebrafish LEC
daughter cells progressively elevate Vegfr3 signaling, conse-
quently elevating Prox1 expression and hence LEC fate is
progressively reinforced as these cells sprout from the PCV.
However, in knockout mice with reduced VEGFC signaling,(C) Confocal projections of prox1a:Venus expression in the posterior cardinal vein (PCV) in sibling (n = 2) and
20 mm.
(D) Number of Prox1-positive (antibody staining) cells in dorsal or ventral PCV in sibling (n = 20) and vegfc-ind
36 hpf. vegfc-induced embryos showed a 5-fold increase in dorsal wall cells and further increase in ventral
(E) Confocal projections of endogenous Prox1 expressing cells (gray) in vegfc-induced (n = 10) and sibling e
(E0) Confocal projections of prox1a:Venus-expressing cells co-stained with endogenous Prox1. In vegfc-in
prox1a:Venus-positive cells compared with control cells (n = 8).
(F) Confocal projections from time lapse of sibling (top) and vegfc-induced (bottom) embryos showing render
LEC, green. Scale bar, 20 mm.
(G) Quantification of daughter cell behaviors from prox1a-positive precursors in vegfc-induced embryos vis
migrated dorsally (2 sprout) and one remained in the PCV; in 35%, both daughter cells migrated dorsally; and
cell divisions scored in n = 10 movies).
1838 Cell Reports 13, 1828–1841, December 1, 2015 ª2015 The AuthorsProx1 expression is still initiated (Bos
et al., 2011; Ha¨gerling et al., 2013; Kark-
kainen et al., 2004), but here we see
reduced or absent Prox1 induction in
zebrafish depleted for Vegfc/Vegfr3
signaling (Figure 5). One difference in ze-brafish may be the role played by maternally deposited Prox1.
It is possible that the maternal contribution (Figures 1I–1K) is suf-
ficient to initiate zygotic Prox1 in zebrafish, a very different sce-
nario to induction of PROX1 transcription in mice. The precise
role of maternal Prox1 and the initial control of Prox1 induction
in the zebrafish requires further analysis before a direct compar-
ison can be drawn.
Asymmetric Cell Division or Asymmetric Daughter Cell
Behaviors?
The division of bipotential precursors that we report here gener-
ates daughter cells that have different behaviors and different
identities. However, we have not shown that the cell division it-
self is asymmetric rather than the asymmetric assignment of
identity following division. We do note that in the observed sce-
nario, an initial asymmetry needs to be present in the system.
How is asymmetry established? One possibility is the shuttling
of a determinant into one daughter cell during the division of bi-
potential LEC/VEC precursors. Such a scenario occurs with the
asymmetric localization of the Prox1 homolog Prospero during
Drosophila neuroblast division (Hirata et al., 1995; Yu et al.,vegfc-induced (n = 8) embryos at 30 hpf. Scale bar,
uced (n = 6) embryos scored across six somites at
wall cells (mean ± SEM).
mbryos (n = 18) (scale bar, 20 mm) at 36 hpf.
duced (n = 11) embryos, Prox1 was present in all
ed prox1a:Venus cells (pre-LEC, yellow; VEC, blue;
ualized in time lapse from 30 hpf. In 42%, one cell
in 23%, both cells remained in the PCV (from n = 17
2006). Another possibility would be through tip-stalk cell-like
signaling to select one active, Vegfc-responsive and one inac-
tive, less responsive cell post-division (e.g., reviewed in Geu-
dens and Gerhardt, 2011). While hypotheses such as these are
attractive, significantly increased depth of resolution will be
needed to directly observe such mechanisms during bipotential
precursor division.
EXPERIMENTAL PROCEDURES
Zebrafish Strains and Transgenesis
Animal work followed guidelines of the animal ethics committees at the Uni-
versity of Queensland. Published transgenic lines and mutants were
Tg(kdrl:Hsa.HRAS-mCherry)s916 (Hogan et al., 2009a), Tg(fli1a:nEGFP)y7 (Law-
son and Weinstein, 2002), Tg(5.2lyve1b:DsRed)nz101 (Okuda et al., 2012),
Tg(fli1a:GALFF)ubs3 (Sauteur et al., 2014), prox1ai278, prox1bsa0035 (van Impel
et al., 2014), and TgBAC(prox1a:KalTA4-4xUAS-ADV.E1b:TagRFP)nim5 (Dun-
worth et al., 2014; van Impel et al., 2014). TgBAC(prox1a:KalTA4-4xUAS-ADV.
E1b:TagRFP)nim5, Tg(fli1a:GALFF)ubs3, Tg(4xUAS:RFP), and prox1ai278,
prox1bsa0035 were kindly provided by the Ober, Affolter, Bakkers, and Ingham
laboratories, respectively. For details on generation of Tg(prox1a:KalTA4)uq3bh,
Tg(10xUAS:vegfc)uq2bh, and MZprox1auq4bh, see Supplemental Experimental
Procedures.
Genotyping and Construct Generation
Tg(10xUAS:vegfc)uq2bh, prox1ai278 and prox1bsa0035 genotyping primers are
described in Supplemental Experimental Procedures. 10xUAS:vegfc plasmid
DNA was generated using the full-length zebrafish vegfc cDNA sequence
cloned into the Gateway pME vector (pDON-221) using Gateway technology
(Hartley et al., 2000). For primer sequences, see Supplemental Experimental
Procedures. Subsequently a Gateway LR reaction was performed combining
a p5E-10xUAS, pME-vegfc and p5E-polyA placing the final 10xUAS:vegfc
sequence into pDestTol2pA2AC (containing the a-crystaline promoter driving
GFP in the zebrafish lens).
10xUAS:H2AmCherry-IRES-GFPCAAX plasmid DNA was generated by a
Gateway LR reaction combining p5E-10xUAS, pME-H2AmCherry and p5E-
IRES-GFPCAAX placing the final 10xUAS:H2AmCherry-IRES-GFPCAAX
sequence into pDestTol2pA2AC. The pME-H2AmCherry and p3E-IRES-
EGFPCAAX were a kind gift from Dr. T. Hall (Parton laboratory, IMB, University
of Queensland).
BAC Recombineering
For the generation of Tg(prox1a:KalTA4)uq3bh transgenic line, we modified the
previously published bacterial artificial chromosome (BAC) plasmid that was
used to generate TgBAC(prox1a:KalTA4-4xUAS-E1b:uncTagRFP)nim5 (Dun-
worth et al., 2014; van Impel et al., 2014).
Two Tol2 LTRs flanking an ampicillin resistance cassette were placed in the
BAC vector backbone using RedET-assisted recombination as previously
described (Bussmann and Schulte-Merker, 2011). To remove the expression
of 4xUAS:uncTagRFP, the 4xUAS sequence (167 bp) was replaced by a
kanamycin resistance cassette using RedET-assisted recombination. The
kanamycin cassette was amplified from a pCS2+Citrine plasmid using the
following primers: prox1a KAN-Forward (prox1a BAC homology arm = under-
lined): 50-GTTTTTTAATTCGCGGCCGCTCTAGAACTAGTGGATCCCCCGGG
CTGCAGCAGCCTGTTGACAATTAATCATCGG-30; and prox1a KAN-Reverse
(prox1a BAC homology arm = underlined): 50-ACTCGCAGATCCGCCAT
GGTGGCGGCGAATTCGTGTGGAGGAGCTCAAAGTCAGAAGAACTCGTCA
AGAAGGCG-30.
Embryo Manipulations and Expression Analysis
MO-ccbe1,MO-vegfr3, andMO-vegfc (Le Guen et al., 2014) andMO-sox7 and
MO-sox18 (Herpers et al., 2008) were used as previously described. 10xUAS:
H2AmCherry-IRES-EGFPCAAX circular DNA (20 ng/ml) and tol2 transposase
mRNA (25 ng/ml) were injected in one-cell-stage embryos. Chemicals were
diluted in E3 water with 1% DMSO (Sigma), and embryos were treated fromCell Re24 hpf to 3 dpf (for details, see Table S1). FACS analysis (at 30 hpf) was per-
formed as previously described (Kartopawiro et al., 2014). For qRT-PCR
primer sequences, see Supplemental Experimental Procedures.
Cellular Transplantation
Transplantation was performed as previously described (Hogan et al., 2009a),
with the following changes. Cells from wild-type Tg(fli1a:nEGFP) donor em-
bryos were transplanted into wild-type recipients. Embryos with successfully
transplanted Tg(fli1a:n EGFP) ECs were imaged from 28 hpf to 3 dpf using
either a Zeiss LSM 710 FCS confocal microscope or a Zeiss Axiovert 200 spin-
ning disc microscope.
Immunohistochemistry
Immunohistochemistry was performed according to a previously pub-
lished protocol (Le Guen et al., 2014) with the following modifications. After
acetone treatment embryos were treated with Proteinase K at 10 mg/ml diluted
in PBS-T. For stage-specific incubation times, see Supplemental Experimental
Procedures.
Antibodies used were chicken a-GFP (1:400, Abcam), rabbit a-DsRed
(1:400, Living colors, Clontech), rabbit a-Prox1 (1:500, AngioBio Co), and
a-rabbit IgG-HRP (1:1,000, Cell Signaling).
Imaging and Quantification
Live and fixed embryos were mounted laterally and imaged using a Zeiss LSM
710 FCS confocal microscope. All images were processed using either
ImarisX64 7.70 and/or ImageJ 1.47 (National Institutes of Health, USA) soft-
ware. Live imaging was performed on laterally mounted embryos imaged
above the yolk-extension between somites 8 and 15. For detailed information
on quantification methods, see Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
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